This compound is a protected nucleotide building block used in the synthesis of oligonucleotides. It features a purine base with an isobutyryl amide protecting group and a dimethoxytrityl (DMT) group for temporary protection of the 5'-hydroxyl, making it suitable for solid-phase DNA/RNA synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 68892-41-1
5'-O-DMT-N2-Isobutyryl-2'-O-methyl-D-guanosine
modified nucleoside for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
Guanosine, 2'-deoxy-N-(2-methyl-1-oxopropyl)-
Pharmaceutical intermediate for nucleoside analogs
2-Bromo-5-iodo-1,3-dimethylbenzene
Pharmaceutical intermediate
Xanthine
pharmaceutical intermediate
1-(4-Chloromethyl-2-thiazoyl)guanidine Hydrochloride Salt
pharmaceutical intermediate
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
nucleoside analog pharmaceutical intermediate
5'-O-DMT-2'-O-iBu-N-Bz-Guanosine
protected guanosine for oligonucleotide synthesis
N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
RMQXDNUKLIDXOS-ZGIBFIJWSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3C[C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O